nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP1A2—Dacarbazine—sarcoma	0.0494	0.141	CbGbCtD
Ziprasidone—CYP3A7—Vincristine—sarcoma	0.0472	0.134	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0472	0.134	CbGbCtD
Ziprasidone—CYP3A4—Thiotepa—sarcoma	0.0467	0.133	CbGbCtD
Ziprasidone—CYP3A5—Vincristine—sarcoma	0.0354	0.101	CbGbCtD
Ziprasidone—CYP3A5—Etoposide—sarcoma	0.0325	0.0924	CbGbCtD
Ziprasidone—CYP1A2—Etoposide—sarcoma	0.0242	0.0688	CbGbCtD
Ziprasidone—HTR1D—meninx—sarcoma	0.0218	0.126	CbGeAlD
Ziprasidone—HTR1B—dura mater—sarcoma	0.0207	0.12	CbGeAlD
Ziprasidone—CYP3A4—Mitoxantrone—sarcoma	0.0201	0.0571	CbGbCtD
Ziprasidone—HTR1D—dura mater—sarcoma	0.02	0.116	CbGeAlD
Ziprasidone—CYP3A4—Vincristine—sarcoma	0.0138	0.0393	CbGbCtD
Ziprasidone—CYP2D6—Doxorubicin—sarcoma	0.0136	0.0387	CbGbCtD
Ziprasidone—CYP3A4—Etoposide—sarcoma	0.0127	0.036	CbGbCtD
Ziprasidone—CYP3A4—Doxorubicin—sarcoma	0.00863	0.0246	CbGbCtD
Ziprasidone—CHRM3—muscle of abdomen—sarcoma	0.00846	0.0491	CbGeAlD
Ziprasidone—HTR7—pulmonary artery—sarcoma	0.00682	0.0396	CbGeAlD
Ziprasidone—HTR2A—pulmonary artery—sarcoma	0.00425	0.0247	CbGeAlD
Ziprasidone—HTR1E—myometrium—sarcoma	0.00335	0.0194	CbGeAlD
Ziprasidone—H1F0—mammary gland—sarcoma	0.00279	0.0162	CbGeAlD
Ziprasidone—HTR2A—hindlimb—sarcoma	0.00257	0.0149	CbGeAlD
Ziprasidone—HTR2A—appendage—sarcoma	0.00221	0.0128	CbGeAlD
Ziprasidone—DRD5—hematopoietic system—sarcoma	0.0022	0.0127	CbGeAlD
Ziprasidone—HTR7—endothelium—sarcoma	0.00213	0.0124	CbGeAlD
Ziprasidone—H1F0—myometrium—sarcoma	0.00198	0.0115	CbGeAlD
Ziprasidone—H1F0—embryo—sarcoma	0.0019	0.011	CbGeAlD
Ziprasidone—DRD4—testis—sarcoma	0.00183	0.0106	CbGeAlD
Ziprasidone—H1F0—seminal vesicle—sarcoma	0.00179	0.0104	CbGeAlD
Ziprasidone—CHRM5—skin of body—sarcoma	0.00171	0.00994	CbGeAlD
Ziprasidone—H1F0—hematopoietic system—sarcoma	0.0017	0.00986	CbGeAlD
Ziprasidone—H1F0—connective tissue—sarcoma	0.00164	0.00949	CbGeAlD
Ziprasidone—HTR3A—hematopoietic system—sarcoma	0.00162	0.0094	CbGeAlD
Ziprasidone—DRD5—lymphoid tissue—sarcoma	0.00155	0.00897	CbGeAlD
Ziprasidone—H1F0—smooth muscle tissue—sarcoma	0.0015	0.00868	CbGeAlD
Ziprasidone—H1F0—skin of body—sarcoma	0.00148	0.00857	CbGeAlD
Ziprasidone—CHRM4—testis—sarcoma	0.00138	0.00801	CbGeAlD
Ziprasidone—HTR2A—endothelium—sarcoma	0.00133	0.00773	CbGeAlD
Ziprasidone—H1F0—cardiac atrium—sarcoma	0.00129	0.00749	CbGeAlD
Ziprasidone—H1F0—uterus—sarcoma	0.00128	0.00745	CbGeAlD
Ziprasidone—HTR1D—connective tissue—sarcoma	0.00127	0.00735	CbGeAlD
Ziprasidone—SLC6A4—hematopoietic system—sarcoma	0.00124	0.00717	CbGeAlD
Ziprasidone—H1F0—lymphoid tissue—sarcoma	0.0012	0.00694	CbGeAlD
Ziprasidone—CYP3A7—liver—sarcoma	0.00119	0.00689	CbGeAlD
Ziprasidone—KCNH2—myometrium—sarcoma	0.00114	0.0066	CbGeAlD
Ziprasidone—H1F0—tendon—sarcoma	0.00112	0.00653	CbGeAlD
Ziprasidone—ADRA2C—myometrium—sarcoma	0.00112	0.00651	CbGeAlD
Ziprasidone—HTR1A—hematopoietic system—sarcoma	0.0011	0.00637	CbGeAlD
Ziprasidone—H1F0—bone marrow—sarcoma	0.00109	0.00632	CbGeAlD
Ziprasidone—HTR7—hematopoietic system—sarcoma	0.00105	0.00608	CbGeAlD
Ziprasidone—KCNH2—seminal vesicle—sarcoma	0.00103	0.00596	CbGeAlD
Ziprasidone—ADRA2C—seminal vesicle—sarcoma	0.00101	0.00588	CbGeAlD
Ziprasidone—ADRA1A—hematopoietic system—sarcoma	0.00101	0.00587	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—liver—sarcoma	0.00101	0.00586	CbGeAlD
Ziprasidone—HTR7—connective tissue—sarcoma	0.00101	0.00586	CbGeAlD
Ziprasidone—KCNH2—hematopoietic system—sarcoma	0.000977	0.00567	CbGeAlD
Ziprasidone—CHRM3—smooth muscle tissue—sarcoma	0.00097	0.00563	CbGeAlD
Ziprasidone—H1F0—testis—sarcoma	0.000931	0.0054	CbGeAlD
Ziprasidone—HTR7—smooth muscle tissue—sarcoma	0.000923	0.00536	CbGeAlD
Ziprasidone—HRH1—myometrium—sarcoma	0.000912	0.00529	CbGeAlD
Ziprasidone—ADRA2A—myometrium—sarcoma	0.000895	0.0052	CbGeAlD
Ziprasidone—H1F0—liver—sarcoma	0.00088	0.00511	CbGeAlD
Ziprasidone—CYP1A2—hematopoietic system—sarcoma	0.000836	0.00485	CbGeAlD
Ziprasidone—ADRA2A—seminal vesicle—sarcoma	0.000809	0.00469	CbGeAlD
Ziprasidone—CYP3A5—hematopoietic system—sarcoma	0.000806	0.00468	CbGeAlD
Ziprasidone—HRH1—hematopoietic system—sarcoma	0.000783	0.00454	CbGeAlD
Ziprasidone—ADRA2A—hematopoietic system—sarcoma	0.000769	0.00446	CbGeAlD
Ziprasidone—HRH1—connective tissue—sarcoma	0.000754	0.00437	CbGeAlD
Ziprasidone—KCNH2—cardiac atrium—sarcoma	0.000742	0.0043	CbGeAlD
Ziprasidone—ADRA2A—connective tissue—sarcoma	0.00074	0.0043	CbGeAlD
Ziprasidone—KCNH2—uterus—sarcoma	0.000738	0.00428	CbGeAlD
Ziprasidone—HTR2A—embryo—sarcoma	0.000732	0.00425	CbGeAlD
Ziprasidone—ADRA2C—cardiac atrium—sarcoma	0.000732	0.00425	CbGeAlD
Ziprasidone—ADRA2C—uterus—sarcoma	0.000728	0.00422	CbGeAlD
Ziprasidone—ADRA1A—lymphoid tissue—sarcoma	0.000712	0.00413	CbGeAlD
Ziprasidone—HTR7—tendon—sarcoma	0.000694	0.00403	CbGeAlD
Ziprasidone—HRH1—smooth muscle tissue—sarcoma	0.000689	0.004	CbGeAlD
Ziprasidone—H1F0—lymph node—sarcoma	0.000675	0.00392	CbGeAlD
Ziprasidone—HTR2A—hematopoietic system—sarcoma	0.000654	0.00379	CbGeAlD
Ziprasidone—ADRA2C—tendon—sarcoma	0.000638	0.0037	CbGeAlD
Ziprasidone—HTR2A—connective tissue—sarcoma	0.000629	0.00365	CbGeAlD
Ziprasidone—KCNH2—bone marrow—sarcoma	0.000626	0.00363	CbGeAlD
Ziprasidone—CYP3A4—hematopoietic system—sarcoma	0.000605	0.00351	CbGeAlD
Ziprasidone—CHRM3—testis—sarcoma	0.000604	0.0035	CbGeAlD
Ziprasidone—CYP2D6—hematopoietic system—sarcoma	0.000596	0.00346	CbGeAlD
Ziprasidone—ADRA2A—cardiac atrium—sarcoma	0.000584	0.00339	CbGeAlD
Ziprasidone—ADRA2A—uterus—sarcoma	0.000581	0.00337	CbGeAlD
Ziprasidone—HTR2A—smooth muscle tissue—sarcoma	0.000576	0.00334	CbGeAlD
Ziprasidone—HTR7—testis—sarcoma	0.000574	0.00333	CbGeAlD
Ziprasidone—DRD2—testis—sarcoma	0.000543	0.00315	CbGeAlD
Ziprasidone—HTR7—liver—sarcoma	0.000543	0.00315	CbGeAlD
Ziprasidone—KCNH2—testis—sarcoma	0.000535	0.00311	CbGeAlD
Ziprasidone—ADRA2C—testis—sarcoma	0.000528	0.00306	CbGeAlD
Ziprasidone—ADRA1A—liver—sarcoma	0.000524	0.00304	CbGeAlD
Ziprasidone—HRH1—tendon—sarcoma	0.000518	0.00301	CbGeAlD
Ziprasidone—ADRA2A—tendon—sarcoma	0.000509	0.00295	CbGeAlD
Ziprasidone—ADRA2C—liver—sarcoma	0.000499	0.0029	CbGeAlD
Ziprasidone—CYP1A2—liver—sarcoma	0.000433	0.00251	CbGeAlD
Ziprasidone—HTR2A—tendon—sarcoma	0.000433	0.00251	CbGeAlD
Ziprasidone—HRH1—testis—sarcoma	0.000429	0.00249	CbGeAlD
Ziprasidone—ADRA2A—testis—sarcoma	0.000421	0.00245	CbGeAlD
Ziprasidone—CYP3A5—liver—sarcoma	0.000418	0.00242	CbGeAlD
Ziprasidone—KCNH2—lymph node—sarcoma	0.000388	0.00225	CbGeAlD
Ziprasidone—ADRA2C—lymph node—sarcoma	0.000383	0.00222	CbGeAlD
Ziprasidone—HTR2A—testis—sarcoma	0.000358	0.00208	CbGeAlD
Ziprasidone—HTR2A—liver—sarcoma	0.000339	0.00197	CbGeAlD
Ziprasidone—CYP2D6—testis—sarcoma	0.000326	0.00189	CbGeAlD
Ziprasidone—Orthostatic hypotension—Doxorubicin—sarcoma	0.000323	0.000727	CcSEcCtD
Ziprasidone—Hypokalaemia—Doxorubicin—sarcoma	0.000322	0.000725	CcSEcCtD
Ziprasidone—Angina pectoris—Epirubicin—sarcoma	0.000322	0.000725	CcSEcCtD
Ziprasidone—Urticaria—Mitoxantrone—sarcoma	0.00032	0.000721	CcSEcCtD
Ziprasidone—Breast disorder—Doxorubicin—sarcoma	0.00032	0.00072	CcSEcCtD
Ziprasidone—Anorexia—Etoposide—sarcoma	0.000319	0.000719	CcSEcCtD
Ziprasidone—Diarrhoea—Thiotepa—sarcoma	0.000319	0.000719	CcSEcCtD
Ziprasidone—Body temperature increased—Mitoxantrone—sarcoma	0.000319	0.000717	CcSEcCtD
Ziprasidone—Abdominal pain—Mitoxantrone—sarcoma	0.000319	0.000717	CcSEcCtD
Ziprasidone—Diarrhoea—Dactinomycin—sarcoma	0.000317	0.000713	CcSEcCtD
Ziprasidone—Nasopharyngitis—Doxorubicin—sarcoma	0.000316	0.000712	CcSEcCtD
Ziprasidone—CYP3A4—liver—sarcoma	0.000314	0.00182	CbGeAlD
Ziprasidone—Hypotension—Etoposide—sarcoma	0.000313	0.000705	CcSEcCtD
Ziprasidone—Gastritis—Doxorubicin—sarcoma	0.000313	0.000705	CcSEcCtD
Ziprasidone—HRH1—lymph node—sarcoma	0.000311	0.0018	CbGeAlD
Ziprasidone—Dysuria—Epirubicin—sarcoma	0.000309	0.000696	CcSEcCtD
Ziprasidone—Dizziness—Thiotepa—sarcoma	0.000309	0.000695	CcSEcCtD
Ziprasidone—CYP2D6—liver—sarcoma	0.000309	0.00179	CbGeAlD
Ziprasidone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000307	0.000691	CcSEcCtD
Ziprasidone—Influenza—Doxorubicin—sarcoma	0.000306	0.000688	CcSEcCtD
Ziprasidone—Dysphagia—Doxorubicin—sarcoma	0.000306	0.000688	CcSEcCtD
Ziprasidone—ADRA2A—lymph node—sarcoma	0.000305	0.00177	CbGeAlD
Ziprasidone—Hypersensitivity—Vincristine—sarcoma	0.000305	0.000686	CcSEcCtD
Ziprasidone—Eosinophilia—Doxorubicin—sarcoma	0.000303	0.000681	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Epirubicin—sarcoma	0.000302	0.000679	CcSEcCtD
Ziprasidone—Paraesthesia—Etoposide—sarcoma	0.000301	0.000678	CcSEcCtD
Ziprasidone—Weight increased—Epirubicin—sarcoma	0.000301	0.000677	CcSEcCtD
Ziprasidone—Weight decreased—Epirubicin—sarcoma	0.000299	0.000673	CcSEcCtD
Ziprasidone—Dyspnoea—Etoposide—sarcoma	0.000299	0.000673	CcSEcCtD
Ziprasidone—Hyperglycaemia—Epirubicin—sarcoma	0.000298	0.000671	CcSEcCtD
Ziprasidone—Somnolence—Etoposide—sarcoma	0.000298	0.000671	CcSEcCtD
Ziprasidone—Angina pectoris—Doxorubicin—sarcoma	0.000298	0.00067	CcSEcCtD
Ziprasidone—Hypersensitivity—Mitoxantrone—sarcoma	0.000297	0.000668	CcSEcCtD
Ziprasidone—Asthenia—Vincristine—sarcoma	0.000297	0.000668	CcSEcCtD
Ziprasidone—Vomiting—Thiotepa—sarcoma	0.000297	0.000668	CcSEcCtD
Ziprasidone—Pneumonia—Epirubicin—sarcoma	0.000296	0.000667	CcSEcCtD
Ziprasidone—Infestation NOS—Epirubicin—sarcoma	0.000295	0.000663	CcSEcCtD
Ziprasidone—Infestation—Epirubicin—sarcoma	0.000295	0.000663	CcSEcCtD
Ziprasidone—Vomiting—Dactinomycin—sarcoma	0.000294	0.000663	CcSEcCtD
Ziprasidone—Rash—Thiotepa—sarcoma	0.000294	0.000662	CcSEcCtD
Ziprasidone—Dermatitis—Thiotepa—sarcoma	0.000294	0.000662	CcSEcCtD
Ziprasidone—Headache—Thiotepa—sarcoma	0.000292	0.000658	CcSEcCtD
Ziprasidone—Rash—Dactinomycin—sarcoma	0.000292	0.000657	CcSEcCtD
Ziprasidone—Decreased appetite—Etoposide—sarcoma	0.000291	0.000656	CcSEcCtD
Ziprasidone—Renal failure—Epirubicin—sarcoma	0.00029	0.000652	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Etoposide—sarcoma	0.000289	0.000651	CcSEcCtD
Ziprasidone—Asthenia—Mitoxantrone—sarcoma	0.000289	0.000651	CcSEcCtD
Ziprasidone—Fatigue—Etoposide—sarcoma	0.000289	0.000651	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Epirubicin—sarcoma	0.000289	0.00065	CcSEcCtD
Ziprasidone—Jaundice—Epirubicin—sarcoma	0.000287	0.000646	CcSEcCtD
Ziprasidone—Constipation—Etoposide—sarcoma	0.000287	0.000645	CcSEcCtD
Ziprasidone—Conjunctivitis—Epirubicin—sarcoma	0.000286	0.000645	CcSEcCtD
Ziprasidone—Dysuria—Doxorubicin—sarcoma	0.000286	0.000644	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000284	0.00064	CcSEcCtD
Ziprasidone—Diarrhoea—Vincristine—sarcoma	0.000283	0.000637	CcSEcCtD
Ziprasidone—Sweating—Epirubicin—sarcoma	0.000282	0.000636	CcSEcCtD
Ziprasidone—Haematuria—Epirubicin—sarcoma	0.000281	0.000632	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Doxorubicin—sarcoma	0.000279	0.000628	CcSEcCtD
Ziprasidone—Weight increased—Doxorubicin—sarcoma	0.000278	0.000626	CcSEcCtD
Ziprasidone—Epistaxis—Epirubicin—sarcoma	0.000278	0.000626	CcSEcCtD
Ziprasidone—Nausea—Thiotepa—sarcoma	0.000277	0.000624	CcSEcCtD
Ziprasidone—Weight decreased—Doxorubicin—sarcoma	0.000277	0.000623	CcSEcCtD
Ziprasidone—Feeling abnormal—Etoposide—sarcoma	0.000276	0.000622	CcSEcCtD
Ziprasidone—Hyperglycaemia—Doxorubicin—sarcoma	0.000276	0.000621	CcSEcCtD
Ziprasidone—Diarrhoea—Mitoxantrone—sarcoma	0.000276	0.000621	CcSEcCtD
Ziprasidone—Nausea—Dactinomycin—sarcoma	0.000275	0.000619	CcSEcCtD
Ziprasidone—Pneumonia—Doxorubicin—sarcoma	0.000274	0.000617	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Etoposide—sarcoma	0.000274	0.000617	CcSEcCtD
Ziprasidone—Dizziness—Vincristine—sarcoma	0.000274	0.000616	CcSEcCtD
Ziprasidone—Infestation NOS—Doxorubicin—sarcoma	0.000273	0.000614	CcSEcCtD
Ziprasidone—Infestation—Doxorubicin—sarcoma	0.000273	0.000614	CcSEcCtD
Ziprasidone—Bradycardia—Epirubicin—sarcoma	0.000269	0.000606	CcSEcCtD
Ziprasidone—Renal failure—Doxorubicin—sarcoma	0.000268	0.000603	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000267	0.000602	CcSEcCtD
Ziprasidone—Urticaria—Etoposide—sarcoma	0.000266	0.000599	CcSEcCtD
Ziprasidone—Haemoglobin—Epirubicin—sarcoma	0.000266	0.000598	CcSEcCtD
Ziprasidone—Jaundice—Doxorubicin—sarcoma	0.000266	0.000598	CcSEcCtD
Ziprasidone—Rhinitis—Epirubicin—sarcoma	0.000265	0.000597	CcSEcCtD
Ziprasidone—Abdominal pain—Etoposide—sarcoma	0.000265	0.000597	CcSEcCtD
Ziprasidone—Body temperature increased—Etoposide—sarcoma	0.000265	0.000597	CcSEcCtD
Ziprasidone—Conjunctivitis—Doxorubicin—sarcoma	0.000265	0.000596	CcSEcCtD
Ziprasidone—Hepatitis—Epirubicin—sarcoma	0.000264	0.000595	CcSEcCtD
Ziprasidone—Haemorrhage—Epirubicin—sarcoma	0.000264	0.000595	CcSEcCtD
Ziprasidone—Hypoaesthesia—Epirubicin—sarcoma	0.000263	0.000592	CcSEcCtD
Ziprasidone—Vomiting—Vincristine—sarcoma	0.000263	0.000592	CcSEcCtD
Ziprasidone—Pharyngitis—Epirubicin—sarcoma	0.000262	0.000591	CcSEcCtD
Ziprasidone—Sweating—Doxorubicin—sarcoma	0.000261	0.000588	CcSEcCtD
Ziprasidone—Urinary tract disorder—Epirubicin—sarcoma	0.000261	0.000588	CcSEcCtD
Ziprasidone—Rash—Vincristine—sarcoma	0.000261	0.000587	CcSEcCtD
Ziprasidone—Dermatitis—Vincristine—sarcoma	0.000261	0.000587	CcSEcCtD
Ziprasidone—Oedema peripheral—Epirubicin—sarcoma	0.00026	0.000586	CcSEcCtD
Ziprasidone—Haematuria—Doxorubicin—sarcoma	0.00026	0.000585	CcSEcCtD
Ziprasidone—Connective tissue disorder—Epirubicin—sarcoma	0.00026	0.000585	CcSEcCtD
Ziprasidone—Urethral disorder—Epirubicin—sarcoma	0.000259	0.000584	CcSEcCtD
Ziprasidone—Headache—Vincristine—sarcoma	0.000259	0.000584	CcSEcCtD
Ziprasidone—Epistaxis—Doxorubicin—sarcoma	0.000257	0.000579	CcSEcCtD
Ziprasidone—Vomiting—Mitoxantrone—sarcoma	0.000256	0.000577	CcSEcCtD
Ziprasidone—Visual impairment—Epirubicin—sarcoma	0.000255	0.000574	CcSEcCtD
Ziprasidone—Rash—Mitoxantrone—sarcoma	0.000254	0.000572	CcSEcCtD
Ziprasidone—Dermatitis—Mitoxantrone—sarcoma	0.000254	0.000571	CcSEcCtD
Ziprasidone—Headache—Mitoxantrone—sarcoma	0.000252	0.000568	CcSEcCtD
Ziprasidone—Bradycardia—Doxorubicin—sarcoma	0.000249	0.000561	CcSEcCtD
Ziprasidone—Eye disorder—Epirubicin—sarcoma	0.000247	0.000556	CcSEcCtD
Ziprasidone—Hypersensitivity—Etoposide—sarcoma	0.000247	0.000556	CcSEcCtD
Ziprasidone—Tinnitus—Epirubicin—sarcoma	0.000247	0.000555	CcSEcCtD
Ziprasidone—Haemoglobin—Doxorubicin—sarcoma	0.000246	0.000554	CcSEcCtD
Ziprasidone—Nausea—Vincristine—sarcoma	0.000246	0.000553	CcSEcCtD
Ziprasidone—Cardiac disorder—Epirubicin—sarcoma	0.000245	0.000553	CcSEcCtD
Ziprasidone—Rhinitis—Doxorubicin—sarcoma	0.000245	0.000552	CcSEcCtD
Ziprasidone—Hepatitis—Doxorubicin—sarcoma	0.000245	0.000551	CcSEcCtD
Ziprasidone—Haemorrhage—Doxorubicin—sarcoma	0.000245	0.000551	CcSEcCtD
Ziprasidone—Hypoaesthesia—Doxorubicin—sarcoma	0.000243	0.000548	CcSEcCtD
Ziprasidone—Pharyngitis—Doxorubicin—sarcoma	0.000243	0.000547	CcSEcCtD
Ziprasidone—Urinary tract disorder—Doxorubicin—sarcoma	0.000242	0.000544	CcSEcCtD
Ziprasidone—Oedema peripheral—Doxorubicin—sarcoma	0.000241	0.000543	CcSEcCtD
Ziprasidone—Asthenia—Etoposide—sarcoma	0.00024	0.000541	CcSEcCtD
Ziprasidone—Connective tissue disorder—Doxorubicin—sarcoma	0.00024	0.000541	CcSEcCtD
Ziprasidone—Angiopathy—Epirubicin—sarcoma	0.00024	0.00054	CcSEcCtD
Ziprasidone—Urethral disorder—Doxorubicin—sarcoma	0.00024	0.00054	CcSEcCtD
Ziprasidone—Nausea—Mitoxantrone—sarcoma	0.000239	0.000539	CcSEcCtD
Ziprasidone—Immune system disorder—Epirubicin—sarcoma	0.000239	0.000538	CcSEcCtD
Ziprasidone—Mediastinal disorder—Epirubicin—sarcoma	0.000238	0.000537	CcSEcCtD
Ziprasidone—Chills—Epirubicin—sarcoma	0.000237	0.000534	CcSEcCtD
Ziprasidone—Arrhythmia—Epirubicin—sarcoma	0.000236	0.000532	CcSEcCtD
Ziprasidone—Visual impairment—Doxorubicin—sarcoma	0.000236	0.000531	CcSEcCtD
Ziprasidone—Alopecia—Epirubicin—sarcoma	0.000234	0.000526	CcSEcCtD
Ziprasidone—Mental disorder—Epirubicin—sarcoma	0.000232	0.000522	CcSEcCtD
Ziprasidone—Erythema—Epirubicin—sarcoma	0.00023	0.000518	CcSEcCtD
Ziprasidone—Malnutrition—Epirubicin—sarcoma	0.00023	0.000518	CcSEcCtD
Ziprasidone—Diarrhoea—Etoposide—sarcoma	0.000229	0.000516	CcSEcCtD
Ziprasidone—Eye disorder—Doxorubicin—sarcoma	0.000229	0.000515	CcSEcCtD
Ziprasidone—Tinnitus—Doxorubicin—sarcoma	0.000228	0.000514	CcSEcCtD
Ziprasidone—Cardiac disorder—Doxorubicin—sarcoma	0.000227	0.000511	CcSEcCtD
Ziprasidone—Flatulence—Epirubicin—sarcoma	0.000227	0.000511	CcSEcCtD
Ziprasidone—Back pain—Epirubicin—sarcoma	0.000223	0.000501	CcSEcCtD
Ziprasidone—Angiopathy—Doxorubicin—sarcoma	0.000222	0.0005	CcSEcCtD
Ziprasidone—Dizziness—Etoposide—sarcoma	0.000222	0.000499	CcSEcCtD
Ziprasidone—Muscle spasms—Epirubicin—sarcoma	0.000221	0.000498	CcSEcCtD
Ziprasidone—Immune system disorder—Doxorubicin—sarcoma	0.000221	0.000498	CcSEcCtD
Ziprasidone—Mediastinal disorder—Doxorubicin—sarcoma	0.000221	0.000496	CcSEcCtD
Ziprasidone—Chills—Doxorubicin—sarcoma	0.00022	0.000494	CcSEcCtD
Ziprasidone—Arrhythmia—Doxorubicin—sarcoma	0.000219	0.000492	CcSEcCtD
Ziprasidone—Vision blurred—Epirubicin—sarcoma	0.000217	0.000488	CcSEcCtD
Ziprasidone—Alopecia—Doxorubicin—sarcoma	0.000216	0.000487	CcSEcCtD
Ziprasidone—Mental disorder—Doxorubicin—sarcoma	0.000214	0.000483	CcSEcCtD
Ziprasidone—Vomiting—Etoposide—sarcoma	0.000213	0.00048	CcSEcCtD
Ziprasidone—Erythema—Doxorubicin—sarcoma	0.000213	0.00048	CcSEcCtD
Ziprasidone—Malnutrition—Doxorubicin—sarcoma	0.000213	0.00048	CcSEcCtD
Ziprasidone—Anaemia—Epirubicin—sarcoma	0.000213	0.000479	CcSEcCtD
Ziprasidone—Agitation—Epirubicin—sarcoma	0.000212	0.000476	CcSEcCtD
Ziprasidone—Rash—Etoposide—sarcoma	0.000211	0.000476	CcSEcCtD
Ziprasidone—Dermatitis—Etoposide—sarcoma	0.000211	0.000475	CcSEcCtD
Ziprasidone—Headache—Etoposide—sarcoma	0.00021	0.000473	CcSEcCtD
Ziprasidone—Flatulence—Doxorubicin—sarcoma	0.00021	0.000473	CcSEcCtD
Ziprasidone—Vertigo—Epirubicin—sarcoma	0.000207	0.000466	CcSEcCtD
Ziprasidone—Syncope—Epirubicin—sarcoma	0.000206	0.000465	CcSEcCtD
Ziprasidone—Leukopenia—Epirubicin—sarcoma	0.000206	0.000464	CcSEcCtD
Ziprasidone—Back pain—Doxorubicin—sarcoma	0.000206	0.000464	CcSEcCtD
Ziprasidone—Muscle spasms—Doxorubicin—sarcoma	0.000205	0.000461	CcSEcCtD
Ziprasidone—Palpitations—Epirubicin—sarcoma	0.000203	0.000458	CcSEcCtD
Ziprasidone—Loss of consciousness—Epirubicin—sarcoma	0.000202	0.000456	CcSEcCtD
Ziprasidone—Cough—Epirubicin—sarcoma	0.000201	0.000452	CcSEcCtD
Ziprasidone—Vision blurred—Doxorubicin—sarcoma	0.000201	0.000452	CcSEcCtD
Ziprasidone—Nausea—Etoposide—sarcoma	0.000199	0.000448	CcSEcCtD
Ziprasidone—Hypertension—Epirubicin—sarcoma	0.000199	0.000447	CcSEcCtD
Ziprasidone—Anaemia—Doxorubicin—sarcoma	0.000197	0.000443	CcSEcCtD
Ziprasidone—Myalgia—Epirubicin—sarcoma	0.000196	0.000441	CcSEcCtD
Ziprasidone—Chest pain—Epirubicin—sarcoma	0.000196	0.000441	CcSEcCtD
Ziprasidone—Arthralgia—Epirubicin—sarcoma	0.000196	0.000441	CcSEcCtD
Ziprasidone—Agitation—Doxorubicin—sarcoma	0.000196	0.000441	CcSEcCtD
Ziprasidone—Anxiety—Epirubicin—sarcoma	0.000195	0.00044	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000195	0.000438	CcSEcCtD
Ziprasidone—Dry mouth—Epirubicin—sarcoma	0.000192	0.000432	CcSEcCtD
Ziprasidone—Vertigo—Doxorubicin—sarcoma	0.000191	0.000431	CcSEcCtD
Ziprasidone—Syncope—Doxorubicin—sarcoma	0.000191	0.00043	CcSEcCtD
Ziprasidone—Leukopenia—Doxorubicin—sarcoma	0.000191	0.000429	CcSEcCtD
Ziprasidone—Confusional state—Epirubicin—sarcoma	0.000189	0.000426	CcSEcCtD
Ziprasidone—Palpitations—Doxorubicin—sarcoma	0.000188	0.000424	CcSEcCtD
Ziprasidone—Loss of consciousness—Doxorubicin—sarcoma	0.000187	0.000421	CcSEcCtD
Ziprasidone—Infection—Epirubicin—sarcoma	0.000187	0.00042	CcSEcCtD
Ziprasidone—Cough—Doxorubicin—sarcoma	0.000186	0.000418	CcSEcCtD
Ziprasidone—Shock—Epirubicin—sarcoma	0.000185	0.000416	CcSEcCtD
Ziprasidone—Nervous system disorder—Epirubicin—sarcoma	0.000184	0.000415	CcSEcCtD
Ziprasidone—Thrombocytopenia—Epirubicin—sarcoma	0.000184	0.000414	CcSEcCtD
Ziprasidone—Hypertension—Doxorubicin—sarcoma	0.000184	0.000414	CcSEcCtD
Ziprasidone—Tachycardia—Epirubicin—sarcoma	0.000183	0.000413	CcSEcCtD
Ziprasidone—Skin disorder—Epirubicin—sarcoma	0.000182	0.000411	CcSEcCtD
Ziprasidone—Hyperhidrosis—Epirubicin—sarcoma	0.000182	0.000409	CcSEcCtD
Ziprasidone—Myalgia—Doxorubicin—sarcoma	0.000181	0.000408	CcSEcCtD
Ziprasidone—Chest pain—Doxorubicin—sarcoma	0.000181	0.000408	CcSEcCtD
Ziprasidone—Arthralgia—Doxorubicin—sarcoma	0.000181	0.000408	CcSEcCtD
Ziprasidone—Anxiety—Doxorubicin—sarcoma	0.000181	0.000407	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00018	0.000405	CcSEcCtD
Ziprasidone—Anorexia—Epirubicin—sarcoma	0.000179	0.000403	CcSEcCtD
Ziprasidone—Dry mouth—Doxorubicin—sarcoma	0.000177	0.000399	CcSEcCtD
Ziprasidone—Hypotension—Epirubicin—sarcoma	0.000176	0.000395	CcSEcCtD
Ziprasidone—Confusional state—Doxorubicin—sarcoma	0.000175	0.000395	CcSEcCtD
Ziprasidone—Infection—Doxorubicin—sarcoma	0.000173	0.000389	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000171	0.000385	CcSEcCtD
Ziprasidone—Shock—Doxorubicin—sarcoma	0.000171	0.000385	CcSEcCtD
Ziprasidone—Nervous system disorder—Doxorubicin—sarcoma	0.00017	0.000384	CcSEcCtD
Ziprasidone—Thrombocytopenia—Doxorubicin—sarcoma	0.00017	0.000383	CcSEcCtD
Ziprasidone—Insomnia—Epirubicin—sarcoma	0.00017	0.000383	CcSEcCtD
Ziprasidone—Tachycardia—Doxorubicin—sarcoma	0.00017	0.000382	CcSEcCtD
Ziprasidone—Skin disorder—Doxorubicin—sarcoma	0.000169	0.00038	CcSEcCtD
Ziprasidone—Paraesthesia—Epirubicin—sarcoma	0.000169	0.00038	CcSEcCtD
Ziprasidone—Hyperhidrosis—Doxorubicin—sarcoma	0.000168	0.000378	CcSEcCtD
Ziprasidone—Dyspnoea—Epirubicin—sarcoma	0.000167	0.000377	CcSEcCtD
Ziprasidone—Somnolence—Epirubicin—sarcoma	0.000167	0.000376	CcSEcCtD
Ziprasidone—Anorexia—Doxorubicin—sarcoma	0.000166	0.000373	CcSEcCtD
Ziprasidone—Dyspepsia—Epirubicin—sarcoma	0.000165	0.000372	CcSEcCtD
Ziprasidone—Decreased appetite—Epirubicin—sarcoma	0.000163	0.000368	CcSEcCtD
Ziprasidone—Hypotension—Doxorubicin—sarcoma	0.000162	0.000366	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000162	0.000365	CcSEcCtD
Ziprasidone—Fatigue—Epirubicin—sarcoma	0.000162	0.000365	CcSEcCtD
Ziprasidone—Constipation—Epirubicin—sarcoma	0.000161	0.000362	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000158	0.000357	CcSEcCtD
Ziprasidone—Insomnia—Doxorubicin—sarcoma	0.000157	0.000354	CcSEcCtD
Ziprasidone—Paraesthesia—Doxorubicin—sarcoma	0.000156	0.000351	CcSEcCtD
Ziprasidone—Dyspnoea—Doxorubicin—sarcoma	0.000155	0.000349	CcSEcCtD
Ziprasidone—Feeling abnormal—Epirubicin—sarcoma	0.000155	0.000349	CcSEcCtD
Ziprasidone—Somnolence—Doxorubicin—sarcoma	0.000155	0.000348	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Epirubicin—sarcoma	0.000154	0.000346	CcSEcCtD
Ziprasidone—Dyspepsia—Doxorubicin—sarcoma	0.000153	0.000345	CcSEcCtD
Ziprasidone—Decreased appetite—Doxorubicin—sarcoma	0.000151	0.00034	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00015	0.000338	CcSEcCtD
Ziprasidone—Fatigue—Doxorubicin—sarcoma	0.00015	0.000337	CcSEcCtD
Ziprasidone—Urticaria—Epirubicin—sarcoma	0.000149	0.000336	CcSEcCtD
Ziprasidone—Constipation—Doxorubicin—sarcoma	0.000149	0.000335	CcSEcCtD
Ziprasidone—Body temperature increased—Epirubicin—sarcoma	0.000149	0.000334	CcSEcCtD
Ziprasidone—Abdominal pain—Epirubicin—sarcoma	0.000149	0.000334	CcSEcCtD
Ziprasidone—Feeling abnormal—Doxorubicin—sarcoma	0.000143	0.000323	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000142	0.00032	CcSEcCtD
Ziprasidone—Hypersensitivity—Epirubicin—sarcoma	0.000138	0.000312	CcSEcCtD
Ziprasidone—Urticaria—Doxorubicin—sarcoma	0.000138	0.000311	CcSEcCtD
Ziprasidone—Abdominal pain—Doxorubicin—sarcoma	0.000137	0.000309	CcSEcCtD
Ziprasidone—Body temperature increased—Doxorubicin—sarcoma	0.000137	0.000309	CcSEcCtD
Ziprasidone—Asthenia—Epirubicin—sarcoma	0.000135	0.000303	CcSEcCtD
Ziprasidone—Diarrhoea—Epirubicin—sarcoma	0.000129	0.000289	CcSEcCtD
Ziprasidone—Hypersensitivity—Doxorubicin—sarcoma	0.000128	0.000288	CcSEcCtD
Ziprasidone—Asthenia—Doxorubicin—sarcoma	0.000125	0.000281	CcSEcCtD
Ziprasidone—Dizziness—Epirubicin—sarcoma	0.000124	0.00028	CcSEcCtD
Ziprasidone—Vomiting—Epirubicin—sarcoma	0.000119	0.000269	CcSEcCtD
Ziprasidone—Diarrhoea—Doxorubicin—sarcoma	0.000119	0.000268	CcSEcCtD
Ziprasidone—Rash—Epirubicin—sarcoma	0.000118	0.000267	CcSEcCtD
Ziprasidone—Dermatitis—Epirubicin—sarcoma	0.000118	0.000266	CcSEcCtD
Ziprasidone—Headache—Epirubicin—sarcoma	0.000118	0.000265	CcSEcCtD
Ziprasidone—Dizziness—Doxorubicin—sarcoma	0.000115	0.000259	CcSEcCtD
Ziprasidone—Nausea—Epirubicin—sarcoma	0.000112	0.000251	CcSEcCtD
Ziprasidone—Vomiting—Doxorubicin—sarcoma	0.000111	0.000249	CcSEcCtD
Ziprasidone—Rash—Doxorubicin—sarcoma	0.00011	0.000247	CcSEcCtD
Ziprasidone—Dermatitis—Doxorubicin—sarcoma	0.00011	0.000247	CcSEcCtD
Ziprasidone—Headache—Doxorubicin—sarcoma	0.000109	0.000245	CcSEcCtD
Ziprasidone—Nausea—Doxorubicin—sarcoma	0.000103	0.000232	CcSEcCtD
Ziprasidone—DRD4—Signaling Pathways—VEGFA—sarcoma	5.64e-06	0.000174	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—EGFR—sarcoma	5.62e-06	0.000174	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—NRAS—sarcoma	5.57e-06	0.000172	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VEGFA—sarcoma	5.56e-06	0.000172	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MDM2—sarcoma	5.56e-06	0.000172	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—HRAS—sarcoma	5.53e-06	0.000171	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—HRAS—sarcoma	5.52e-06	0.00017	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—KRAS—sarcoma	5.51e-06	0.00017	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—NRAS—sarcoma	5.49e-06	0.00017	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MDM2—sarcoma	5.47e-06	0.000169	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—SRC—sarcoma	5.47e-06	0.000169	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CREB1—sarcoma	5.46e-06	0.000168	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—KRAS—sarcoma	5.43e-06	0.000167	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MYC—sarcoma	5.42e-06	0.000167	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MYC—sarcoma	5.42e-06	0.000167	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—KRAS—sarcoma	5.41e-06	0.000167	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PLCG1—sarcoma	5.4e-06	0.000167	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—KRAS—sarcoma	5.4e-06	0.000167	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MYC—sarcoma	5.38e-06	0.000166	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—KRAS—sarcoma	5.38e-06	0.000166	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—HRAS—sarcoma	5.34e-06	0.000165	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—KRAS—sarcoma	5.33e-06	0.000164	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VEGFA—sarcoma	5.33e-06	0.000164	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—sarcoma	5.32e-06	0.000164	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—KRAS—sarcoma	5.31e-06	0.000164	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—HRAS—sarcoma	5.31e-06	0.000164	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—EGFR—sarcoma	5.31e-06	0.000164	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—EGFR—sarcoma	5.3e-06	0.000164	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MYC—sarcoma	5.27e-06	0.000163	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—EGFR—sarcoma	5.27e-06	0.000162	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NRAS—sarcoma	5.26e-06	0.000162	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—EGFR—sarcoma	5.23e-06	0.000161	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—SRC—sarcoma	5.21e-06	0.000161	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MYC—sarcoma	5.19e-06	0.00016	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CCND1—sarcoma	5.19e-06	0.00016	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—JUN—sarcoma	5.17e-06	0.00016	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—HRAS—sarcoma	5.17e-06	0.000159	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—EGFR—sarcoma	5.16e-06	0.000159	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—SRC—sarcoma	5.14e-06	0.000159	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	5.14e-06	0.000158	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—sarcoma	5.13e-06	0.000158	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MYC—sarcoma	5.12e-06	0.000158	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—sarcoma	5.11e-06	0.000158	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—HRAS—sarcoma	5.08e-06	0.000157	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VEGFA—sarcoma	5.07e-06	0.000157	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—EGFR—sarcoma	5.07e-06	0.000157	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MDM2—sarcoma	5.05e-06	0.000156	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NRAS—sarcoma	5.01e-06	0.000155	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—KRAS—sarcoma	5.01e-06	0.000155	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VEGFA—sarcoma	5.01e-06	0.000155	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—KRAS—sarcoma	5.01e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CCND1—sarcoma	5.01e-06	0.000154	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—EGFR—sarcoma	5e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—JUN—sarcoma	5e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CCND1—sarcoma	4.98e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—KRAS—sarcoma	4.97e-06	0.000153	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—JUN—sarcoma	4.97e-06	0.000153	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—sarcoma	4.97e-06	0.000153	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MDM2—sarcoma	4.96e-06	0.000153	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CTNNB1—sarcoma	4.96e-06	0.000153	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MDM2—sarcoma	4.95e-06	0.000153	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NRAS—sarcoma	4.95e-06	0.000153	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MDM2—sarcoma	4.94e-06	0.000152	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—KRAS—sarcoma	4.94e-06	0.000152	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CTNNB1—sarcoma	4.93e-06	0.000152	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MDM2—sarcoma	4.92e-06	0.000152	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MYC—sarcoma	4.9e-06	0.000151	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—sarcoma	4.89e-06	0.000151	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MDM2—sarcoma	4.87e-06	0.00015	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—KRAS—sarcoma	4.87e-06	0.00015	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MDM2—sarcoma	4.86e-06	0.00015	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CCND1—sarcoma	4.84e-06	0.000149	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—JUN—sarcoma	4.83e-06	0.000149	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	4.8e-06	0.000148	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—EGFR—sarcoma	4.79e-06	0.000148	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—KRAS—sarcoma	4.79e-06	0.000148	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CCND1—sarcoma	4.77e-06	0.000147	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—JUN—sarcoma	4.76e-06	0.000147	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—KRAS—sarcoma	4.73e-06	0.000146	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	4.72e-06	0.000146	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—HRAS—sarcoma	4.69e-06	0.000145	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MYC—sarcoma	4.67e-06	0.000144	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—SRC—sarcoma	4.64e-06	0.000143	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—HRAS—sarcoma	4.61e-06	0.000142	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MYC—sarcoma	4.61e-06	0.000142	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—HRAS—sarcoma	4.6e-06	0.000142	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—HRAS—sarcoma	4.59e-06	0.000142	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—HRAS—sarcoma	4.57e-06	0.000141	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—EGFR—sarcoma	4.57e-06	0.000141	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—HRAS—sarcoma	4.53e-06	0.00014	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—KRAS—sarcoma	4.53e-06	0.00014	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—sarcoma	4.52e-06	0.00014	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MDM2—sarcoma	4.52e-06	0.000139	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—HRAS—sarcoma	4.52e-06	0.000139	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—sarcoma	4.51e-06	0.000139	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—EGFR—sarcoma	4.51e-06	0.000139	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—SRC—sarcoma	4.48e-06	0.000138	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NRAS—sarcoma	4.47e-06	0.000138	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SRC—sarcoma	4.46e-06	0.000138	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—sarcoma	4.45e-06	0.000137	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—sarcoma	4.45e-06	0.000137	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—sarcoma	4.44e-06	0.000137	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—sarcoma	4.43e-06	0.000137	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—sarcoma	4.42e-06	0.000136	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—sarcoma	4.41e-06	0.000136	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—sarcoma	4.4e-06	0.000136	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCND1—sarcoma	4.4e-06	0.000136	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—JUN—sarcoma	4.39e-06	0.000135	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—sarcoma	4.36e-06	0.000135	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—sarcoma	4.36e-06	0.000134	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CTNNB1—sarcoma	4.35e-06	0.000134	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—sarcoma	4.34e-06	0.000134	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—sarcoma	4.34e-06	0.000134	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SRC—sarcoma	4.34e-06	0.000134	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—sarcoma	4.33e-06	0.000134	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCND1—sarcoma	4.32e-06	0.000133	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—JUN—sarcoma	4.32e-06	0.000133	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCND1—sarcoma	4.32e-06	0.000133	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—KRAS—sarcoma	4.31e-06	0.000133	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NRAS—sarcoma	4.31e-06	0.000133	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—JUN—sarcoma	4.31e-06	0.000133	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCND1—sarcoma	4.3e-06	0.000133	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—JUN—sarcoma	4.29e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NRAS—sarcoma	4.29e-06	0.000132	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCND1—sarcoma	4.29e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CTNNB1—sarcoma	4.28e-06	0.000132	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—JUN—sarcoma	4.28e-06	0.000132	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CTNNB1—sarcoma	4.27e-06	0.000132	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SRC—sarcoma	4.27e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HRAS—sarcoma	4.26e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CTNNB1—sarcoma	4.26e-06	0.000131	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—sarcoma	4.26e-06	0.000131	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—KRAS—sarcoma	4.26e-06	0.000131	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HRAS—sarcoma	4.26e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCND1—sarcoma	4.25e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CTNNB1—sarcoma	4.25e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—JUN—sarcoma	4.24e-06	0.000131	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCND1—sarcoma	4.23e-06	0.000131	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HRAS—sarcoma	4.23e-06	0.00013	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—JUN—sarcoma	4.23e-06	0.00013	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—sarcoma	4.22e-06	0.00013	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CTNNB1—sarcoma	4.2e-06	0.00013	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—sarcoma	4.2e-06	0.00013	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HRAS—sarcoma	4.2e-06	0.000129	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	4.19e-06	0.000129	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NRAS—sarcoma	4.17e-06	0.000129	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MYC—sarcoma	4.16e-06	0.000128	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—sarcoma	4.16e-06	0.000128	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HRAS—sarcoma	4.14e-06	0.000128	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NRAS—sarcoma	4.11e-06	0.000127	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HRAS—sarcoma	4.07e-06	0.000126	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EGFR—sarcoma	4.07e-06	0.000126	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—sarcoma	4.04e-06	0.000125	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—sarcoma	4.02e-06	0.000124	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HRAS—sarcoma	4.02e-06	0.000124	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MYC—sarcoma	4.02e-06	0.000124	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MYC—sarcoma	3.99e-06	0.000123	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCND1—sarcoma	3.93e-06	0.000121	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SRC—sarcoma	3.93e-06	0.000121	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EGFR—sarcoma	3.93e-06	0.000121	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—JUN—sarcoma	3.93e-06	0.000121	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EGFR—sarcoma	3.91e-06	0.000121	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	3.9e-06	0.00012	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MYC—sarcoma	3.89e-06	0.00012	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SRC—sarcoma	3.87e-06	0.000119	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SRC—sarcoma	3.86e-06	0.000119	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SRC—sarcoma	3.85e-06	0.000119	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HRAS—sarcoma	3.85e-06	0.000119	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—KRAS—sarcoma	3.84e-06	0.000119	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SRC—sarcoma	3.84e-06	0.000118	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—sarcoma	3.83e-06	0.000118	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—sarcoma	3.83e-06	0.000118	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MYC—sarcoma	3.82e-06	0.000118	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SRC—sarcoma	3.8e-06	0.000117	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EGFR—sarcoma	3.8e-06	0.000117	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SRC—sarcoma	3.79e-06	0.000117	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NRAS—sarcoma	3.78e-06	0.000117	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—sarcoma	3.78e-06	0.000117	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—sarcoma	3.77e-06	0.000116	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—sarcoma	3.76e-06	0.000116	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—sarcoma	3.75e-06	0.000116	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EGFR—sarcoma	3.74e-06	0.000115	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—sarcoma	3.74e-06	0.000115	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NRAS—sarcoma	3.72e-06	0.000115	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NRAS—sarcoma	3.72e-06	0.000115	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—KRAS—sarcoma	3.71e-06	0.000114	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NRAS—sarcoma	3.7e-06	0.000114	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—sarcoma	3.7e-06	0.000114	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NRAS—sarcoma	3.69e-06	0.000114	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—sarcoma	3.69e-06	0.000114	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—KRAS—sarcoma	3.69e-06	0.000114	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HRAS—sarcoma	3.67e-06	0.000113	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NRAS—sarcoma	3.66e-06	0.000113	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NRAS—sarcoma	3.65e-06	0.000113	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HRAS—sarcoma	3.62e-06	0.000112	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—KRAS—sarcoma	3.59e-06	0.000111	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—KRAS—sarcoma	3.53e-06	0.000109	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MYC—sarcoma	3.53e-06	0.000109	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SRC—sarcoma	3.52e-06	0.000109	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MYC—sarcoma	3.47e-06	0.000107	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MYC—sarcoma	3.46e-06	0.000107	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MYC—sarcoma	3.45e-06	0.000106	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EGFR—sarcoma	3.45e-06	0.000106	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MYC—sarcoma	3.44e-06	0.000106	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—sarcoma	3.43e-06	0.000106	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—sarcoma	3.42e-06	0.000105	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MYC—sarcoma	3.41e-06	0.000105	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MYC—sarcoma	3.4e-06	0.000105	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EGFR—sarcoma	3.39e-06	0.000105	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NRAS—sarcoma	3.39e-06	0.000105	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EGFR—sarcoma	3.39e-06	0.000104	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EGFR—sarcoma	3.37e-06	0.000104	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EGFR—sarcoma	3.36e-06	0.000104	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EGFR—sarcoma	3.33e-06	0.000103	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EGFR—sarcoma	3.32e-06	0.000103	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—sarcoma	3.3e-06	0.000102	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—sarcoma	3.28e-06	0.000101	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HRAS—sarcoma	3.27e-06	0.000101	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—KRAS—sarcoma	3.26e-06	0.000101	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—KRAS—sarcoma	3.21e-06	9.89e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—KRAS—sarcoma	3.2e-06	9.87e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—sarcoma	3.19e-06	9.85e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—KRAS—sarcoma	3.19e-06	9.84e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—KRAS—sarcoma	3.18e-06	9.81e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MYC—sarcoma	3.16e-06	9.74e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HRAS—sarcoma	3.15e-06	9.73e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—KRAS—sarcoma	3.15e-06	9.71e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—sarcoma	3.14e-06	9.69e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—KRAS—sarcoma	3.14e-06	9.68e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HRAS—sarcoma	3.14e-06	9.68e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EGFR—sarcoma	3.09e-06	9.53e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HRAS—sarcoma	3.05e-06	9.42e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HRAS—sarcoma	3e-06	9.27e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—KRAS—sarcoma	2.92e-06	9e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—sarcoma	2.9e-06	8.93e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—sarcoma	2.85e-06	8.79e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—sarcoma	2.84e-06	8.77e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—sarcoma	2.83e-06	8.74e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—sarcoma	2.82e-06	8.72e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—sarcoma	2.8e-06	8.63e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—sarcoma	2.79e-06	8.61e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HRAS—sarcoma	2.77e-06	8.54e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—HRAS—sarcoma	2.72e-06	8.41e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HRAS—sarcoma	2.72e-06	8.39e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HRAS—sarcoma	2.71e-06	8.36e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HRAS—sarcoma	2.7e-06	8.34e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HRAS—sarcoma	2.67e-06	8.25e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HRAS—sarcoma	2.67e-06	8.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—sarcoma	2.59e-06	8e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HRAS—sarcoma	2.48e-06	7.65e-05	CbGpPWpGaD
